Saturday, July 25, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, July 25 '26)

 


    Ann Intern Med

  1. JOHNSON D, Quinn S, Algase LF, Watkins C Jr, et al
    Telemedicine Policy and Practice: A Position Paper From the American College of Physicians.
    Ann Intern Med. 2026 May 12. doi: 10.7326/ANNALS-25-04194.
    PubMed         Abstract available


    BMC Pediatr

  2. KHALILIAN MR, Goudarzi A, Karimi A, Fahimzad A, et al
    Echocardiographic assessment of cardiac involvement in pediatric COVID-19 patients: a cross-sectional study.
    BMC Pediatr. 2026;26:677.
    PubMed         Abstract available


    J Clin Microbiol

  3. LUUKINEN B, Lang M, Peltola M, Soinila A, et al
    From triplex to tetraplex: evaluation of the diagnostic accuracy of the new Roche Cobas Liat SARS-CoV-2, influenza A/B & RSV assay.
    J Clin Microbiol. 2026 Jul 20:e0027426. doi: 10.1128/jcm.00274.
    PubMed         Abstract available


    J Infect Dis

  4. ZHOU W
    Repeated Influenza Vaccination in Children: Effect Scale, Timing, and Causal Interpretation.
    J Infect Dis. 2026 Jul 24:jiag386. doi: 10.1093.
    PubMed        


    J Virol

  5. FAN M, Liu Z, Deng L, Zheng Y, et al
    LncRNA ckATP1A1-AS1 inhibits influenza A virus replication by mediating innate immune responses and suppressing viral nuclear import.
    J Virol. 2026 Jul 24:e0025926. doi: 10.1128/jvi.00259.
    PubMed         Abstract available

  6. ADENUGBA AR, Bohn P, Yu J, Fehrholz M, et al
    Sequence heterogeneity in pneumonia virus of mice reveals G gene-dependent modulation of virulence.
    J Virol. 2026;100:e0010326.
    PubMed         Abstract available

  7. MURRAY A, Nagaraj D, Schultz EM, Aloisio G, et al
    RSV can infect the human nasal epithelium via the basolateral route and shows distinct subgroup infectivity and basal cell tropism.
    J Virol. 2026;100:e0037426.
    PubMed         Abstract available

  8. AO Z, Vendramelli R, Buyu M, Truong T, et al
    A VSV-vector vaccine simultaneously targeting H5N1 hemagglutinin and matrix protein 2 induces robust neutralizing and ADCC antibody responses and provides full protection against lethal H5N1 infection in a mouse model.
    J Virol. 2026 Jun 16:e0009726. doi: 10.1128/jvi.00097.
    PubMed         Abstract available

  9. ZHANG Q, Xin J, Wang C, Zhang X, et al
    Cleavage of TOM1 by the SARS-CoV-2 main protease NSP5 prevents autophagic degradation of viral envelope.
    J Virol. 2026 Jun 12:e0043426. doi: 10.1128/jvi.00434.
    PubMed         Abstract available

  10. GIL-REDONDO JC, Riomoros-Barahona V, Valiente L, Valbuena A, et al
    Different mechanisms for human rhinovirus survival in the presence of deleterious amino acid substitutions at virion protein-protein or RNA-protein interfaces.
    J Virol. 2026;100:e0051126.
    PubMed         Abstract available

  11. WILT I, Jolley AA, Rahman K, Lai KK, et al
    IFITM1 and IFITM3 cooperate to restrict virus entry in endolysosomes.
    J Virol. 2026;100:e0067726.
    PubMed         Abstract available

  12. VARGAS DA, Albornoz LL, Pena-Morales M, Ortiz Rojas HJ, et al
    Within-host SARS-CoV-2 diversity in immunocompromised patients during acute infection.
    J Virol. 2026 Jun 9:e0222425. doi: 10.1128/jvi.02224.
    PubMed         Abstract available

  13. YU H-M, Zhu M-L, Zhao Y-L, Tan J-X, et al
    Research progress on the association between viruses and cardiac diseases.
    J Virol. 2026 Jun 9:e0038326. doi: 10.1128/jvi.00383.
    PubMed         Abstract available


    J Virol Methods

  14. HSIEH YH, Su CC, Lee CC, Chen PL, et al
    Analytical characteristics of the NeuMoDx SARS-CoV-2 assay and clinical agreement with the BD MAX system.
    J Virol Methods. 2026;345:115431.
    PubMed         Abstract available

  15. WANG B, Wang J, Sun Z, Sun G, et al
    Epidemiological characteristics of respiratory syncytial virus in children during 2021-2024.
    J Virol Methods. 2026;345:115433.
    PubMed         Abstract available


    Pediatrics

  16. KAO CM, Bahakel H, Heald-Sargent TA, Minniear TD, et al
    Influenza, COVID-19, and RSV Vaccinations for Immunocompromised Children and Household Contacts.
    Pediatrics. 2026 Jul 23:e2026075971. doi: 10.1542/peds.2026-075971.
    PubMed         Abstract available


    PLoS Genet

  17. WEYKOPF G, Bickmore WA, Biddie SC, Friman ET, et al
    Identifying severe COVID-19 risk variants modulating enhancer reporter activity in lung cells.
    PLoS Genet. 2026;22:e1012222.
    PubMed         Abstract available


    PLoS Med

  18. LI W, Yang W, Liu Y, Yao Y, et al
    Assessing spatial transmission risk of respiratory infectious diseases across cities of different socioeconomic tiers in China: A modelling study.
    PLoS Med. 2026;23:e1005172.
    PubMed         Abstract available

  19. GRAIS RF
    Whose fears count? Legitimacy, trust and viral outbreak responses after COVID-19.
    PLoS Med. 2026;23:e1005184.
    PubMed         Abstract available


    PLoS One

  20. CHURCHILL BF, Gao XS, Rong R
    Partisan differences in healthcare decision-making: Evidence from a vaccine experiment.
    PLoS One. 2026;21:e0352319.
    PubMed         Abstract available

  21. SCHEPISI C, Ventura M, Di Napoli A, Aragona M, et al
    The effect of COVID-19 and socioeconomic inequalities on emergency department accesses for psychiatric conditions.
    PLoS One. 2026;21:e0324305.
    PubMed         Abstract available

  22. SUZUKI T, Kita Y, Yanagida K, Maeda K, et al
    Molecular signature of COVID-19 prior to its exacerbation by multi-omics survey.
    PLoS One. 2026;21:e0352423.
    PubMed         Abstract available

  23. ELLIS K, Hall P, Robinson L, Ruiz S, et al
    COVID-19 vaccine confidence among adults of pima county using the NIMHD minority health and health disparities research framework: A qualitative analysis.
    PLoS One. 2026;21:e0353345.
    PubMed         Abstract available

  24. HIRSCH JA, Besser LM, Pescador Jimenez M, Dickinson ST, et al
    Spatial and neighborhood data in the collaborative cohort of cohorts for COVID-19 Research (C4R).
    PLoS One. 2026;21:e0352170.
    PubMed         Abstract available

  25. LA EM, Gallington K, Singer D, Fikre T, et al
    US healthcare professionals' knowledge, attitudes, and practices regarding RSV disease and vaccination in adults during the 2024-2025 RSV season.
    PLoS One. 2026;21:e0353266.
    PubMed         Abstract available

  26. HAMUNAKWADI DL, Smith SL
    The news media and the agenda for noncommunicable diseases before and during the COVID-19 pandemic: Losing the competition for coverage and framing responsibility for action in Malawi.
    PLoS One. 2026;21:e0341285.
    PubMed         Abstract available

  27. IBRAHIM S, Yakubu Y, Appiagyei K, Sylvester AFD, et al
    Factors associated with severe acute respiratory syndrome coronavirus-2 infection in Hohoe Municipality, Ghana: A case-control study.
    PLoS One. 2026;21:e0332561.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  28. MISTRY HB
    Hazard curvature makes within-host variability costly for survival.
    Proc Natl Acad Sci U S A. 2026;123:e2610568123.
    PubMed         Abstract available


    Vaccine

  29. OKOLI GN, Sullivan SG, Harper DM, Tsang TK, et al
    A systematic meta-analytic comparative evaluation of seasonal influenza vaccine effectiveness from test-negative design studies in the Northern Hemisphere pre/post COVID-19 pandemic.
    Vaccine. 2026;88:128956.
    PubMed         Abstract available

  30. WANG WC, Alhashimi M, Gairola V, Murala MST, et al
    Lung-resident T-cell immunity dominates protection induced by an intranasal adenoviral nucleoprotein influenza vaccine.
    Vaccine. 2026;88:128962.
    PubMed         Abstract available


    Virology

  31. YOSHIDA K, Yamamoto S, Ogasawara N, Taniguchi K, et al
    Innate immune-regulated sulfated glycosaminoglycans are associated with progeny respiratory syncytial virus retention at the cell surface in immortalized cell lines.
    Virology. 2026;623:110974.
    PubMed         Abstract available

  32. DICKERSON A, Cruceanu A, Pokharel BR, Majumdar N, et al
    Deciphering the miR-29c-3p / TET3 regulatory axis within the SARS-CoV-2-infected midbrain.
    Virology. 2026;623:110989.
    PubMed         Abstract available

  33. WANG Z, Pan Q, Arduini A, Liang C, et al
    Identification of SARS-CoV-2 proteins suppressing host protein synthesis.
    Virology. 2026;623:111006.
    PubMed         Abstract available

  34. MANDVIWALA AS, Liman K, Huckriede ALW, Mishra AC, et al
    Evaluation of MPLA and chimeric TLR agonist adjuvants in RSV virus-like particle vaccines delivered by the intramuscular route.
    Virology. 2026;623:111007.
    PubMed         Abstract available

  35. ABDEL-MONEIM AS, Al-Balushi MS, Al-Jabri AA
    Post-COVID-19 immune dysregulation and autoimmune sequelae.
    Virology. 2026;623:111017.
    PubMed         Abstract available


    Virus Res

  36. TANG Y, Gao X, Ding H, Kong L, et al
    Biological Aging, Immune Phenotypes, and Susceptibility to COVID-19 and Sepsis: A Mendelian Randomization Study.
    Virus Res. 2026;370:199756.
    PubMed         Abstract available

No comments:

Post a Comment

My New Space

Most Popular Posts